Detalles de la búsqueda
1.
Dual CTLA-4 and PD-1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first-in-human, dose-escalation, and dose-expansion study.
Cancer
; 130(11): 1991-2002, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38404184
2.
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.
Br J Cancer
; 129(10): 1608-1618, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37731023
3.
Willingness to receive the second booster of COVID-19 vaccine among older adults with cancer: a stratified analysis in four provinces of China.
Front Public Health
; 12: 1298070, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38454989
4.
Low uptake of COVID-19 booster doses among elderly cancer patients in China: A multicentre cross-sectional study.
J Glob Health
; 14: 05010, 2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38303680
5.
Concerns related to the interactions between COVID-19 vaccination and cancer/cancer treatment were barriers to complete primary vaccination series among Chinese cancer patients: A multicentre cross-sectional survey.
Hum Vaccin Immunother
; 19(2): 2222648, 2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37314490
6.
Hesitancy to Receive the Booster Doses of COVID-19 Vaccine Among Cancer Patients in China: A Multicenter Cross-Sectional Survey - Four PLADs, China, 2022.
China CDC Wkly
; 5(10): 223-228, 2023 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37006443
7.
Cyr61 overexpression induced by interleukin 8 via NF-kB signaling pathway and its role in tumorigenesis of gastric carcinoma in vitro.
Int J Clin Exp Pathol
; 12(9): 3197-3207, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31934164
Resultados
1 -
7
de 7
1
Próxima >
>>